What does the research say about autophagy?

What does the research say about autophagy?

Autophagy is the regulated, lysosome-dependent degradation of cytoplasmic components, including damaged organelles and aggregated proteins. It is not a single molecule but a multi-step pathway; the term covers macroautophagy, microautophagy and chaperone-mediated autophagy, with macroautophagy the most studied. The evidence below spans in vitro, animal and human studies, and the model is stated for each finding.

The work centres on the autophagy initiation complex and its upstream regulation by nutrient and stress signalling, particularly the ULK1-containing complex and the ATG13 subunit, together with downstream lysosomal and proteasomal quality-control pathways.

Research Studies

ATG13 and influenza A virus restriction in cell models

ATG13 is an autophagy-associated protein that regulates assembly of the autophagy initiation complex. In coimmunoprecipitation assays, ATG13 was reported to interact with MAVS and recruit the E3 ubiquitin ligase ASB1, catalysing K63-linked polyubiquitination at the K348 residue of MAVS. This amplified downstream antiviral signalling and potentiated type I interferon activation, restricting influenza A virus replication in the experimental systems used [2].

Astrocytic autophagy-lysosomal impairment in Parkinson's disease models

A system-level review of Parkinson's disease pathogenesis proposed that astrocyte dysfunction is an active driver rather than a passive consequence. In that model, pathological α-synuclein triggers a cycle of astrocytic failure that includes impaired proteostasis through both the ubiquitin-proteasome and autophagy-lysosomal pathways, alongside glymphatic collapse linked to aquaporin-4 depolarisation and neuroinflammation involving microglial crosstalk and the NLRP3 inflammasome [1].

LSD1, ATM demethylation and senescence in aged organs

LSD1 was found to be upregulated in aged organs and senescent cells. In response to natural ageing or ionising radiation-induced DNA damage, LSD1 interacted with and demethylated ATM at lysine 3,016, sustaining ATM phosphorylation and amplifying DNA damage signalling, which promoted senescence and organ ageing in the models studied [3].

Fisetin and amyloid-beta neurotoxicity in SH-SY5Y cells

In an in vitro model of Aβ1-42-induced neurotoxicity using human neuroblastoma SH-SY5Y cells, fisetin was evaluated with in silico target prediction and in vitro validation. Fisetin was predicted to bind with high stability to ULK1 (an autophagy marker), p21 (a senescence and cell-cycle marker) and synaptophysin (a synaptic marker) [7]. These are cell-based and computational findings; no human outcome data are reported in this source.

Astaxanthin and granulosa-cell autophagy in PMOS-associated infertility

A triple-blind, placebo-controlled pilot randomised trial enrolled fifty women with polyendocrine metabolic ovarian syndrome (PMOS)-related anovulatory infertility between November 2023 and September 2024. Participants received astaxanthin (12 mg/day) or placebo. The trial evaluated whether astaxanthin modulates autophagy-related signalling in granulosa cells and how those molecular effects relate to ovarian response [6]. This is a pilot trial; the evidence is specific to the population and intervention studied.

Fasting, exercise and diet in depression

A registered clinical study is examining how lifestyle factors such as physical activity and diet-related processes may influence biological mechanisms linked to depression, with a focus on autophagy as a natural cellular process influenced by energy availability [5]. This is an ongoing study; no results are reported here.

Inorganic phosphate and skeletal muscle energetics

Evidence reviewed in the context of ultra-processed food intake suggests that chronic excess of inorganic phosphate additives may impair skeletal muscle energetics and cardiorespiratory fitness. Inorganic phosphate additives are nearly completely absorbed in the gastrointestinal tract, contributing to habitual intake exceeding the recommended daily allowance by two- to three-fold in many western populations [8]. The mechanisms discussed include effects on cellular quality control, but the source does not establish a human dose-response for autophagy.

Autophagy in hypothalamic POMC and AgRP neurons

In the arcuate nucleus, autophagy exerts divergent metabolic effects in the two principal appetite-regulating neuronal populations, POMC and AgRP neurons. This work links hypothalamic nutrient sensing, leptin responsiveness and intracellular quality control in obesity models [9].

Hepassocin, AMPK and liver senescence

Hepassocin (HPS), a hepatokine with known hepatoprotective functions, was reported to prevent age-related liver senescence and facilitate liver regeneration by activating AMPK in the models studied [10].

Radiation-induced atrial fibrillation and senolytic rescue

In a model of radiation-induced heart disease, cellular senescence driven by the GATA4–NF-κB pathway was implicated in atrial fibrillation susceptibility following ionising radiation, and senolytic therapy with D/Q was reported to rescue the phenotype [11].

Prevotella intermedia and alveolar macrophage function

Culture supernatant from Prevotella intermedia was reported to impair alveolar macrophage function and promote Mycobacterium avium persistence in the experimental system used, in the context of nontuberculous mycobacterial pulmonary disease [12].

Natural medicines for Alzheimer's disease: bibliometric and narrative synthesis

A bibliometric analysis and narrative review mapped research trends in natural medicines for Alzheimer's disease using publications from the Web of Science Core Collection between 1 January 2001 and 28 April 2025. The synthesis examined representative mechanistic evidence, including autophagy-related pathways, but the authors note that the relationship between bibliometric themes and experimental evidence remains insufficiently characterised [4].

If you are reading this for personal health reasons

The materials and findings described here are for laboratory research use only. We do not provide dosing, medical guidance or recommendations for personal use. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

• [1] Convergent Astrocytic Failure in Parkinson's Disease: A System-Level Model of Pathogenesis and Treatment
• [2] ATG13 promotes K63-linked polyubiquitination of MAVS via ASB1 to restrict influenza A virus replication
• [3] LSD1-mediated demethylation of the DNA damage response factor ATM promotes senescence and organ aging
• [4] Research Trends and Mechanistic Insights Into Natural Medicines for Alzheimer's Disease: A Bibliometric Analysis and Narrative Review
• [5] Fasting, Exercise, and Diet to Activate Autophagy in Depression
• [6] Autophagy activation in granulosa cells as a mechanism of astaxanthin action: evidence from a pilot randomised trial in PMOS-associated infertility
• [7] Fisetin Attenuates Amyloid-Beta-Induced Neurotoxicity in Human Neuroblastoma SH-SY5Y Cells: Integrating In Silico Target Prediction and In Vitro Validation
• [8] Inorganic phosphate: a link between processed food and exercise intolerance in the modern world
• [9] Autophagy in hypothalamic POMC and AgRP neurons: mechanisms and therapeutic implications for obesity
• [10] Hepassocin prevents age-related liver senescence and facilitates liver regeneration by activating AMPK
• [11] Radiation-induced atrial fibrillation is driven by cellular senescence via the GATA4 - NF-κB pathway and rescued by D/Q senolytic therapy
• [12] Prevotella intermedia culture supernatant impairs alveolar macrophage function and promotes Mycobacterium avium persistence